Chosa Oncology AB

NEW
FRA:W5L (Sweden)  
€ 0.056 -0.0046 (-7.62%) Jul 8
At Loss
P/B:
3.17
Market Cap:
€ 5.94M ($ 6.79M)
Enterprise V:
€ 5.15M ($ 5.88M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Description
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.91
Piotroski F-Score
4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
24.59
9-Day RSI
34.19
14-Day RSI
39.76
3-1 Month Momentum %
9.06
6-1 Month Momentum %
-16.67
12-1 Month Momentum %
38.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
3.28
Quick Ratio
3.28
Cash Ratio
2.64

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-57.2
Shareholder Yield %
-10.13
Name Current Vs Industry Vs History
ROE %
-6.62
ROA %
-5.88
ROIC %
-7.06
3-Year ROIIC %
-64.2
ROCE %
-10.73

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio
3.17
Price-to-Operating-Cash-Flow
111.86
EV-to-EBIT
-33.11
EV-to-EBITDA
-57.36
EV-to-FCF
-14.69
Earnings Yield (Greenblatt) %
-3.02
FCF Yield %
-6.59

Financials (Next Earnings Date:2026-08-27)

FRA:W5L's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Chosa Oncology AB Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.001
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 105.97
14-Day RSI 39.76
14-Day ATR (€) 0.003197
20-Day SMA (€) 0.06475
12-1 Month Momentum % 38.3
52-Week Range (€) 0.033 - 0.154
Shares Outstanding (Mil) 87.86

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Chosa Oncology AB Filings

Filing Date Document Date Form
No Filing Data

Chosa Oncology AB Stock Events

Financials Calendars
Event Date Price (€)
Third quarter earnings results for 2026 2026-11-19 In 133 days
Second quarter earnings results for 2026 2026-08-27 In 49 days
First quarter earnings results for 2026 2026-05-30 0.06 (+0.00%)
General meeting for 2025 2026-05-27 10:00 0.06 (+0.00%)
Annual report for 2025 2026-05-06 0.07 (+0.00%)
Fourth quarter earnings results for 2025 2026-02-26 0.06 (+0.00%)
Third quarter earnings results for 2025 2025-11-13 0.09 (+0.00%)
Second quarter earnings results for 2025 2025-08-28 0.06 (+0.00%)
General meeting for 2024 2025-06-13 13:00 0.05 (+0.00%)
First quarter earnings results for 2025 2025-05-30 0.05 (+0.00%)
Show
Entries

Chosa Oncology AB Frequently Asked Questions

What is Chosa Oncology AB(FRA:W5L)'s stock price today?
The current price of FRA:W5L is €0.06. The 52 week high of FRA:W5L is €0.15 and 52 week low is €0.03.
When is next earnings date of Chosa Oncology AB(FRA:W5L)?
The next earnings date of Chosa Oncology AB(FRA:W5L) is 2026-08-27.
Does Chosa Oncology AB(FRA:W5L) pay dividends? If so, how much?
Chosa Oncology AB(FRA:W5L) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Chosa Oncology AB

No articles.